Target intelligence / Profile preview

Cellular oxidative and nitrosative pathways (ROS/RNS pathways)

Target
ROS/RNS pathways
Molecular classification
Other
01

Overview

Cellular oxidative and nitrosative pathways encompass the biochemical processes involved in the production, regulation, and neutralization of reactive oxygen species (ROS) and reactive nitrogen species (RNS). These pathways play a dual role in cellular physiology: at low to moderate levels, ROS and RNS act as critical signaling molecules in processes like cell growth, differentiation, and immune response [Source: NIH, Frontiers]. However, an imbalance between the production of these reactive species and the antioxidant defense systems leads to oxidative and nitrosative stress, which causes damage to DNA, proteins, and lipids [Source: MDPI]. This dysregulation is a hallmark of numerous pathologies, including cancer, neurodegenerative diseases, and cardiovascular disorders [Source: PubMed]. Therapeutic strategies often focus on restoring redox balance through the use of antioxidants, Nrf2 activators, or inhibitors of specific ROS/RNS-generating enzymes like NADPH oxidase (NOX) and nitric oxide synthase (NOS) [Source: ResearchGate]. Despite their potential, targeting these pathways is challenging because maintaining basal levels of reactive species is essential for normal physiological functions, such as vascular tone regulation and pathogen defense [Source: NIH].

Other names
Oxidative stress pathwaysNitrosative stress pathwaysRedox signaling pathwaysReactive oxygen and nitrogen species pathways
02

Mechanism of action

Drugs targeting these pathways act by scavenging reactive species, inducing endogenous antioxidant defenses via the Nrf2 pathway, or inhibiting enzymes like NOX and NOS that produce ROS and RNS.

03

Biological functions

Signal transductionApoptosisCell deathImmune responseMetabolismHomeostasis
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetesAging
05

Safety considerations

Disruption of physiological redox signalingPotential pro-oxidant effectsImpairment of immune-mediated pathogen killingDisruption of vascular homeostasis
06

Interacting drugs

N-acetylcysteine

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)3-NitrotyrosineGlutathione (GSH/GSSG) ratioProtein carbonyls

Beyond the preview

Go deeper on Cellular oxidative and nitrosative pathways (ROS/RNS pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular oxidative and nitrosative pathways (ROS/RNS pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call